Cases & Deals

  • Home
  • Practices
  • National digital health company considers new services offering involving controlled substances

Share

National digital health company considers new services offering involving controlled substances

May 2025

Client(s) National digital health company

Jones Day advised a national digital health company on the federal and state regulatory considerations in connection with a new services offering involving the prescription of controlled substances.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.